Voloridge Investment Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
2,222,841
+1,748,040
| +368% | +$10M | 0.05% | 470 |
|
|
2025
Q1 | $3.87M | Sell |
474,801
-405,311
| -46% | -$3.31M | 0.01% | 842 |
|
|
2024
Q4 | $8.29M | Sell |
880,112
-397,497
| -31% | -$3.74M | 0.03% | 632 |
|
|
2024
Q3 | $13.6M | Sell |
1,277,609
-18,626
| -1% | -$199K | 0.05% | 482 |
|
|
2024
Q2 | $12.9M | Sell |
1,296,235
-16,935
| -1% | -$168K | 0.05% | 505 |
|
|
2024
Q1 | $15.5M | Buy |
1,313,170
+578,303
| +79% | +$6.81M | 0.06% | 387 |
|
|
2023
Q4 | $10.4M | Buy |
+734,867
| New | +$10.4M | 0.04% | 467 |
|
|
2022
Q3 | – | Sell |
-47,952
| Closed | -$515K | – | 1468 |
|
|
2022
Q2 | $515K | Buy |
47,952
+2,706
| +6% | +$29.1K | ﹤0.01% | 1296 |
|
|
2022
Q1 | $428K | Sell |
45,246
-222,600
| -83% | -$2.11M | ﹤0.01% | 1235 |
|
|
2021
Q4 | $3.09M | Sell |
267,846
-331,999
| -55% | -$3.84M | 0.02% | 907 |
|
|
2021
Q3 | $5.73M | Sell |
599,845
-338,887
| -36% | -$3.24M | 0.04% | 627 |
|
|
2021
Q2 | $9.05M | Sell |
938,732
-823,133
| -47% | -$7.93M | 0.06% | 440 |
|
|
2021
Q1 | $17.4M | Buy |
1,761,865
+1,596,072
| +963% | +$15.8M | 0.13% | 206 |
|
|
2020
Q4 | $3.83M | Buy |
165,793
+73,797
| +80% | +$1.7M | 0.03% | 517 |
|
|
2020
Q3 | $1.3M | Sell |
91,996
-2,479
| -3% | -$35K | 0.01% | 855 |
|
|
2020
Q2 | $1.43M | Buy |
94,475
+2,530
| +3% | +$38.2K | 0.02% | 725 |
|
|
2020
Q1 | $850K | Buy |
+91,945
| New | +$850K | 0.02% | 555 |
|
|
2017
Q4 | – | Sell |
-362,440
| Closed | -$5.47M | – | 524 |
|
|
2017
Q3 | $5.47M | Buy |
362,440
+61,297
| +20% | +$924K | 0.12% | 168 |
|
|
2017
Q2 | $3.03M | Buy |
+301,143
| New | +$3.03M | 0.08% | 232 |
|